Breast Cancer Management in North Carolina: Updates for 2020 LIVE
Dr. Emily Ray, from the UNC Lineberger Breast Oncology group, will describe relevant updates in systemic therapy for breast cancers for health care providers throughout the state of North Carolina.
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.
Recognize the options for adjuvant therapy in early stage HER2+ breast cancer
Describe the role of genomic assays in determining adjuvant treatment for early stage hormone receptor-positive (HR+) breast cancer
Define the options for treating metastatic HER2+ breast cancer
Emily Ray, MD, MPH
Presenter Disclosure Information
Emily Ray, MD, MPH, has no relevant financial relationships with commercial interests as defined by the ACCME.
The Greensboro Area Health Education Center is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Approved by the UNC Eshelman School of Pharmacy for ACPE.
Approved by the American Society of Radiologic Technologists (ASRT).
The UNC School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation
UNC Lineberger Cancer Network certificate of participation.
Tim Poe, Director of Telehealth